Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2006 | 06-2006 | 03-2006 | 12-2005 | 09-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,530,400 | 1,656,800 | 834,800 | 1,979,600 | 1,279,000 |
| Depreciation Amortization | 628,200 | 414,000 | 204,900 | 726,400 | 501,300 |
| Income taxes - deferred | 130,500 | 120,700 | 99,800 | -347,500 | -205,000 |
| Accounts receivable | N/A | N/A | N/A | -286,400 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | -1,463,400 | N/A |
| Other Working Capital | -1,318,600 | -1,357,300 | -947,100 | -1,947,100 | -1,796,000 |
| Other Operating Activity | 147,700 | 108,000 | 62,100 | 3,252,000 | 1,320,000 |
| Operating Cash Flow | $2,118,200 | $942,200 | $254,500 | $1,913,600 | $1,099,300 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 580,400 | 103,900 | -20,200 | 62,700 | 833,100 |
| PPE Investments | -667,800 | -392,100 | -160,700 | -1,287,000 | -878,500 |
| Purchase Of Investment | -1,218,700 | -1,003,200 | -630,700 | -1,183,100 | -271,900 |
| Sale Of Investment | 1,135,100 | 906,200 | 554,800 | 545,100 | 327,000 |
| Other Investing Activity | 124,400 | 126,900 | 85,100 | -353,600 | -216,400 |
| Investing Cash Flow | $-46,600 | $-258,300 | $-171,700 | $-2,215,900 | $-206,700 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -1,800 | 4,900 | 3,800 | -1,988,700 | -1,984,600 |
| Debt Issued | -1,599,000 | -100,100 | -97,700 | 3,000,000 | 1,998,000 |
| Debt Repayment | N/A | N/A | N/A | -1,004,700 | N/A |
| Common Stock Issued | 44,200 | 13,900 | 7,800 | 105,900 | 71,200 |
| Common Stock Repurchased | -122,100 | -122,100 | -122,100 | -377,900 | N/A |
| Dividend Paid | -1,301,500 | -864,600 | -433,500 | -1,654,900 | -1,245,700 |
| Other Financing Activity | 6,300 | 200 | 1,400 | 39,800 | 33,200 |
| Financing Cash Flow | $-2,973,900 | $-1,067,800 | $-640,300 | $-1,880,500 | $-1,127,900 |
| Exchange Rate Effect | 65,500 | 46,900 | 9,100 | -175,800 | -160,300 |
| Beginning Cash Position | 3,006,700 | 3,006,700 | 3,006,700 | 5,365,300 | 5,365,300 |
| End Cash Position | 2,169,900 | 2,669,700 | 2,458,300 | 3,006,700 | 4,969,700 |
| Net Cash Flow | $-836,800 | $-337,000 | $-548,400 | $-2,358,600 | $-395,600 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,118,200 | 942,200 | 254,500 | 1,913,600 | 1,099,300 |
| Capital Expenditure | -667,800 | -392,100 | -160,700 | -1,298,100 | -878,500 |
| Free Cash Flow | 1,450,400 | 550,100 | 93,800 | 615,500 | 220,800 |